Metagenomi Therapeutics (MGX) Q1 2025 Earnings

Mar 17Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-1.19
-0.89
-0.59
-0.29

Details

Expected EPS
-0.7489
Actual EPS
-0.37
Surprise EPS
0.38
Surprise Percent
+50.59%

Description

⁨Metagenomi Therapeutics⁩ (⁦MGX⁩) has reported earnings of ⁦-0.37⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts